Prognostic Value of the Preoperative Lymphocyte-to-C-Reactive Protein Ratio and Albumin-to-Globulin Ratio in Patients with Osteosarcoma

References

• Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment - where do we stand? A state of the art review. Cancer Treat Rev. 2014;40(4):523–532. doi:10.1016/j.ctrv.2013.11.00624345772
   PubMed Web of Science ®Google Scholar
• Li M, Jin X, Li H, Yang C, Deng S, Wu G. Comprehensive analysis of key genes and regulatory elements in osteosarcoma affected by bone matrix mineral with prognostic values. Front Genet. 2020;11:533. doi:10.3389/fgene.2020.0053332582282
   PubMed Web of Science ®Google Scholar
• Janeway KA, Grier HE. Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. Lancet Oncol. 2010;11(7):670–678. doi:10.1016/S1470-2045(10)70062-020347613
   PubMed Web of Science ®Google Scholar
• Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20(3):776–790. doi:10.1200/JCO.2002.20.3.77611821461
   PubMed Web of Science ®Google Scholar
• Zhu N, Hou J, Ma G, Guo S, Zhao C, Chen B. Co-expression network analysis identifies a gene signature as a predictive biomarker for energy metabolism in osteosarcoma. Cancer Cell Int. 2020;20:259. doi:10.1186/s12935-020-01352-232581649
   PubMed Web of Science ®Google Scholar
• Yang M. Prognostic role of pathologic fracture in osteosarcoma: evidence based on 1677 subjects. J Cancer Res Ther. 2015;11(2):264–267. doi:10.4103/0973-1482.15142826148581
   PubMed Web of Science ®Google Scholar
• Kaste SC, Liu T, Billups CA, Daw NC, Pratt CB, Meyer WH. Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity. Pediatr Blood Cancer. 2004;43(7):723–728. doi:10.1002/pbc.2007715390310
   PubMed Web of Science ®Google Scholar
• Buddingh EP, Anninga JK, Versteegh MI, et al. Prognostic factors in pulmonary metastasized high-grade osteosarcoma. Pediatr Blood Cancer. 2010;54(2):216–221. doi:10.1002/pbc.2229319890902
   PubMed Web of Science ®Google Scholar
• Ren HY, Sun LL, Li HY, Ye ZM. Prognostic significance of serum alkaline phosphatase level in osteosarcoma: a meta-analysis of published data. Biomed Res Int. 2015;2015:160835. doi:10.1155/2015/16083526618165
   PubMed Web of Science ®Google Scholar
• Marais LC, Bertie J, Rodseth R, Sartorius B, Ferreira N. Pre-treatment serum lactate dehydrogenase and alkaline phosphatase as predictors of metastases in extremity osteosarcoma. J Bone Oncol. 2015;4(3):80–84. doi:10.1016/j.jbo.2015.09.00226587373
   PubMed Web of Science ®Google Scholar
• Yang Q, Chen T, Yao Z, Zhang X. Prognostic value of pre-treatment Naples prognostic score (NPS) in patients with osteosarcoma. World J Surg Oncol. 2020;18(1):24. doi:10.1186/s12957-020-1789-z32000789
   PubMed Web of Science ®Google Scholar
• Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature. 2011;480(7378):480–489. doi:10.1038/nature1067322193102
   PubMed Web of Science ®Google Scholar
• Kanda M, Mizuno A, Tanaka C, et al. Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer. Medicine (Baltimore). 2016;95(24):e3781. doi:10.1097/MD.000000000000378127310954
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature0720518650914
   PubMed Web of Science ®Google Scholar
• Dinc T, Yildiz BD, Kayilioglu I, Sozen I, Tez M, Coskun F. Prognostic value of preoperative inflammation-based prognostic scores on hospital mortality after gastric cancer surgery. Asian Pac J Cancer Prev. 2014;15(18):7909–7911. doi:10.7314/APJCP.2014.15.18.790925292085
   PubMedGoogle Scholar
• Xu WZ, Li F, Xu ZK, et al. Preoperative albumin-to-globulin ratio and prognostic nutrition index predict prognosis for glioblastoma. Onco Targets Ther. 2017;10:725–733. doi:10.2147/OTT.S12744128223828
   PubMed Web of Science ®Google Scholar
• Li K, Xu Y, Hu Y, Liu Y, Chen X, Zhou Y. Effect of enteral immunonutrition on immune, inflammatory markers and nutritional status in gastric cancer patients undergoing gastrectomy: a randomized double-blinded controlled trial. J Invest Surg. 2019. doi:10.1080/08941939.2019.1569736
   Web of Science ®Google Scholar
• Alifano M, Mansuet-Lupo A, Lococo F, et al. Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer. PLoS One. 2014;9(9):e106914. doi:10.1371/journal.pone.010691425238252
   PubMed Web of Science ®Google Scholar
• Giannousi Z, Gioulbasanis I, Pallis AG, et al. Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis. Support Care Cancer. 2012;20(8):1823–1829. doi:10.1007/s00520-011-1282-x21959842
   PubMed Web of Science ®Google Scholar
• Sánchez-Lara K, Turcott JG, Juárez E, et al. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study. Nutr Cancer. 2012;64(4):526–534. doi:10.1080/01635581.2012.66874422489794
   PubMed Web of Science ®Google Scholar
• Toiyama Y, Shimura T, Yasuda H, et al. Clinical burden of C-reactive protein/albumin ratio before curative surgery for patients with gastric cancer. Anticancer Res. 2016;36(12):6491–6498. doi:10.21873/anticanres.1124827919972
   PubMed Web of Science ®Google Scholar
• Li YJ, Yao K, Lu MX, Zhang WB, Xiao C, Tu CQ. Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma. Onco Targets Ther. 2017;10:5255–5261. doi:10.2147/OTT.S14056029138578
   PubMed Web of Science ®Google Scholar
• Okugawa Y, Toiyama Y, Yamamoto A, et al. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer. Clin Nutr (Edinburgh, Scotland). 2020;39(4):1209–1217. doi:10.1016/j.clnu.2019.05.009
   PubMed Web of Science ®Google Scholar
• Saito H, Kono Y, Murakami Y, et al. Prognostic significance of the preoperative ratio of C-reactive protein to albumin and neutrophil-lymphocyte ratio in gastric cancer patients. World J Surg. 2018;42(6):1819–1825. doi:10.1007/s00268-017-4400-129270656
   PubMed Web of Science ®Google Scholar
• Huang X, Hu H, Zhang W, Shao Z. Prognostic value of prognostic nutritional index and systemic immune-inflammation index in patients with osteosarcoma. J Cell Physiol. 2019;234(10):18408–18414. doi:10.1002/jcp.2847630891768
   PubMed Web of Science ®Google Scholar
• Liu B, Huang Y, Sun Y, et al. Prognostic value of inflammation-based scores in patients with osteosarcoma. Sci Rep. 2016;6:39862. doi:10.1038/srep3986228008988
   PubMed Web of Science ®Google Scholar
• Liu T, Fang X-C, Ding Z, Sun Z-G, Sun L-M, Wang Y-L. Pre-operative lymphocyte-to-monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma. FEBS Open Biol. 2015;5:682–687. doi:10.1016/j.fob.2015.08.002
   PubMed Web of Science ®Google Scholar
• He Y, Gong R, Peng K-W, Liu L-Z, Sun L-Y, Wang H-Y. Lymphocyte-to-C-reactive protein ratio is a potential new prognostic biomarker for patients with lung cancer. Biomark Med. 2020;14:717–726. doi:10.2217/bmm-2019-045232643402
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang B, Zhu K, et al. Preoperative albumin-to-globulin ratio predicts survival in patients with non-small-cell lung cancer after surgery. J Cell Physiol. 2019;234(3):2471–2479. doi:10.1002/jcp.2676630317549
   PubMed Web of Science ®Google Scholar
• Yu S-T, Zhou Z, Cai Q, et al. Prognostic value of the C-reactive protein/albumin ratio in patients with laryngeal squamous cell carcinoma. Onco Targets Ther. 2017;10:879–884. doi:10.2147/OTT.S12839128243123
   PubMed Web of Science ®Google Scholar
• Cai L, Song Y, Zhao X. Prognostic significance of lymphocyte monocyte ratio in patients with ovarian cancer. Medicine (Baltimore). 2020;99(14):e19638. doi:10.1097/MD.000000000001963832243392
   PubMed Web of Science ®Google Scholar
• Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92(3):205–216. doi:10.1093/jnci/92.3.20510655437
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.01321376230
   PubMed Web of Science ®Google Scholar
• Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–503. doi:10.1016/S1470-2045(14)70263-325281468
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhu JY, Zhou LN, Tang M, Chen MB, Tao M. Predicting the prognosis of gastric cancer by albumin/globulin ratio and the prognostic nutritional index. Nutr Cancer. 2020;72(4):635–644. doi:10.1080/01635581.2019.165134731423840
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet (London, England). 2001;357(9255):539–545. doi:10.1016/S0140-6736(00)04046-0
   PubMed Web of Science ®Google Scholar
• Heikkilä K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health. 2007;61(9):824–833. doi:10.1136/jech.2006.05129217699539
   PubMed Web of Science ®Google Scholar
• Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30(7):1073–1081. doi:10.1093/carcin/bgp12719468060
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–899. doi:10.1016/j.cell.2010.01.02520303878
   PubMed Web of Science ®Google Scholar
• Wang H, Ding Y, Li N, et al. Prognostic value of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in stage IV advanced gastric cancer. Front Oncol. 2020;10:841. doi:10.3389/fonc.2020.0084132637353
   PubMed Web of Science ®Google Scholar
• Cheng CB, Zhang QX, Zhuang LP, Sun JW. Prognostic value of lymphocyte-to-C-reactive protein ratio in patients with gastric cancer after surgery: a multicentre study. Jpn J Clin Oncol. 2020;50:1141–1149. doi:10.1093/jjco/hyaa09932564084
   PubMed Web of Science ®Google Scholar
• Baba H, Kuwabara K, Ishiguro T, et al. C-reactive protein as a significant prognostic factor for stage IV gastric cancer patients. Anticancer Res. 2013;33(12):5591–5595.24324103
   PubMed Web of Science ®Google Scholar
• Nozoe T, Iguchi T, Adachi E, Matsukuma A, Ezaki T. Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer. Surg Today. 2011;41(4):510–513. doi:10.1007/s00595-009-4297-x21431483
   PubMed Web of Science ®Google Scholar
• Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009;137(2):425–428. doi:10.1016/j.jtcvs.2008.05.04619185164
   PubMed Web of Science ®Google Scholar
• Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69. doi:10.1186/1475-2891-9-6921176210
   PubMed Web of Science ®Google Scholar
• Hill LA, Bodnar TS, Weinberg J, Hammond GL. Corticosteroid-binding globulin is a biomarker of inflammation onset and severity in female rats. J Endocrinol. 2016;230(2):215–225. doi:10.1530/JOE-16-004727418032
   PubMed Web of Science ®Google Scholar
• Li Q, Meng X, Liang L, Xu Y, Cai G, Cai S. High preoperative serum globulin in rectal cancer treated with neoadjunctive chemoradiation therapy is a risk factor for poor outcome. Am J Cancer Res. 2015;5(9):2856–2864.26609491
   PubMed Web of Science ®Google Scholar
• Sun Y, Huang Z, Lin H, Chi P. Prognostic impact of preoperative immunonutritional status in rectal mucinous adenocarcinoma. Future Oncol. 2020;16(8):339–351. doi:10.2217/fon-2019-079332067478
   PubMed Web of Science ®Google Scholar
• Oki S, Toiyama Y, Okugawa Y, et al. Clinical burden of preoperative albumin-globulin ratio in esophageal cancer patients. Am J Surg. 2017;214(5):891–898. doi:10.1016/j.amjsurg.2017.04.00728460738
   PubMed Web of Science ®Google Scholar